|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.410 USD | +1.26% |
|
+0.84% | +33.89% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 194M 170M 157M 145M 273M 18.72B 277M 1.88B 737M 9.16B 729M 713M 31.57B | P/E 2026 * |
12.4x | P/E 2027 * | 48.2x |
|---|---|---|---|---|---|
| Enterprise Value | 194M 170M 157M 145M 273M 18.72B 277M 1.88B 737M 9.16B 729M 713M 31.57B | EV / Sales 2026 * |
2.48x | EV / Sales 2027 * | 2.87x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | +1.26% | ||
| 1 week | +0.84% | ||
| Current month | +3.43% | ||
| 1 month | +8.56% | ||
| 3 months | +6.17% | ||
| 6 months | +17.56% | ||
| Current year | +33.89% |
| 1 week | 2.25 |  | 2.45 |
| 1 month | 2.13 | | 2.48 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.41 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Executive Officer | 56,000 | 0.0696% | ||
| 18/11/25 | Sell | Director | 168 | 0.0002% | ||
| 03/09/25 | Free | Director | 22,500 | 0.0282% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.26% | +0.84% | +66.21% | +40.12% | 194M | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,023B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 599B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 448B | |
| -0.93% | +0.55% | +28.64% | +19.74% | 326B | |
| +1.50% | +2.12% | +36.56% | +36.98% | 278B | |
| -0.11% | +0.21% | +21.09% | +15.04% | 258B | |
| -1.88% | +1.11% | -21.33% | -41.71% | 222B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 197B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 165B | |
| Average | +0.12% | -0.26% | +31.23% | +46.62% | 351.53B | |
| Weighted average by Cap. | +0.06% | -1.18% | +35.48% | +70.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 68.63M 63.44M 58.34M 110M 7.55B 112M 759M 297M 3.69B 294M 288M 12.73B | 67.56M 59.22M 54.74M 50.34M 94.99M 6.52B 96.52M 655M 257M 3.19B 254M 248M 10.98B |
| Net income | 15.72M 13.78M 12.74M 11.72M 22.1M 1.52B 22.46M 152M 59.71M 742M 59.04M 57.75M 2.56B | 4.07M 3.57M 3.3M 3.04M 5.73M 393M 5.82M 39.46M 15.47M 192M 15.3M 14.96M 662M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | $2.410 | +1.26% | 643,857 |
| 17/07/26 | $2.380 | +3.03% | 549,893 |
| 16/07/26 | $2.310 | -0.86% | 561,378 |
| 15/07/26 | $2.330 | +0.87% | 576,680 |
| 14/07/26 | $2.310 | -3.35% | 813,462 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
